Profiel
Steve Damment is the founder of Aluztura Bio Ltd. which is founded in 2014, where he holds the title of Chief Science Officer.
He held the position of Senior Vice President-Biosciences at Shire Plc from 2000 to 2013 and at GSK Plc from 1982 to 1999.
He also held the position of Executive Vice President-Research & Development at Biodexa Pharmaceuticals Plc from 2018 to 2021.
Dr. Damment received his undergraduate degree from The University of Liverpool.
Actieve functies van Steve Damment
| Bedrijven | Functie | Begin |
|---|---|---|
Aluztura Bio Ltd. | Oprichter | 01-01-2014 |
Eerdere bekende functies van Steve Damment
| Bedrijven | Functie | Einde |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Hoofd Techniek/Wetenschap/O&O | 30-09-2021 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | 01-12-2013 |
| GSK PLC | Corporate Officer/Principal | 01-12-1999 |
Opleiding van Steve Damment
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Aluztura Bio Ltd. |
















